Shiitake Benefits: Lentinan Evidence, Dose & UK Labels

About the author...

Will founded Supermushrooms after digging into the research behind mushroom and nootropic supplements. Every pick is checked against clinical dosing, extract standardisation, and real buyer reviews, and each star rating starts from a product's real Amazon score before being adjusted for formulation quality. Read more about how ratings are calculated.

The strongest evidence for lentinan, shiitake's signature immune compound, comes from injectable drug formulations used alongside chemotherapy in Japan and China. It doesn't come from the oral capsules and powders sold as UK supplements. Oral shiitake still shows real immune activity in human trials, but at a smaller scale, through a slower and far less efficient route into the body.

That gap between "what lentinan has been shown to do" and "what a shiitake capsule can actually deliver" is the most misunderstood point in mushroom supplement marketing. Search "shiitake benefits" and you'll find pages quoting cancer-trial statistics next to an ordinary pot of capsules, as if the two are interchangeable. They aren't. Understanding why matters more than any single dosage number.

This guide covers what lentinan is, what the evidence supports in each setting, why oral bioavailability limits it, and how to read a UK supplement label. It complements our full shiitake mushroom supplement comparison, which ranks specific UK products, rather than repeating it.

Key Takeaways (TL;DR)

• Lentinan is a beta-1,3/1,6-glucan unique to shiitake (Lentinula edodes), studied for over five decades as an immune-modulating compound.
• The cancer-survival data comes almost entirely from injectable pharmaceutical lentinan (2-10mg/week IV) used as adjuvant chemotherapy in Japan and China, not oral supplements.
• Oral lentinan's absolute bioavailability is estimated at roughly 1.5-3%, because its large molecular weight resists gut absorption.
• A four-week human trial of daily dried shiitake still found measurable immune changes (raised gamma-delta T-cells and salivary IgA) at food-level intake.
• On UK labels, look for fruiting body sourcing and a stated beta-glucan or polysaccharide percentage rather than a bare "lentinan" claim with no number attached.
• No UK-sold shiitake supplement is a medicine: none are licensed to treat, prevent, or support recovery from cancer or any disease.

What Lentinan Actually Is

Lentinan is a large beta-1,3-glucan with beta-1,6 side branches, extracted from the fruiting body of the shiitake mushroom. It was first purified in the 1970s. By the early 1980s, Japanese researchers had already mapped its antitumor activity in detail. That early work helped make shiitake one of the most studied medicinal mushrooms in the world.¹

Lentinan sits in the same broad family as the beta-glucans found in reishi, turkey tail, and oats. What makes it distinct is its branching pattern and its very large size, roughly 400,000 to 1,000,000 daltons. That size cuts both ways. It's part of why the immune system recognises lentinan so readily. But it's also the main reason oral absorption is so poor, a point worth keeping in mind before comparing a supplement dose to a clinical one.

Lentinan doesn't kill pathogens or tumour cells directly. Instead it works as a biological response modifier: it binds to receptors on macrophages and dendritic cells, and this in turn activates natural killer (NK) cells and cytotoxic T-cells. Lab and animal studies show lentinan-stimulated macrophages become far more active against target cells than unstimulated ones. Human cell studies have identified the resulting killer cells as CD16+/CD56+, the marker profile for NK cells. This immune-priming action, rather than any direct toxic effect, is the basis for nearly all of lentinan's studied uses.

The Cancer Evidence: What It Actually Shows (and Doesn't)

This is the part most shiitake marketing glosses over, so it's worth being direct. Lentinan has been used clinically in Japan and China for decades as an add-on to chemotherapy, mainly for gastric, colorectal, and lung cancer. It's given by intravenous or intramuscular injection, at doses of roughly 2 to 10mg per week. That's not an oral capsule.

A multi-institutional Japanese study of patients with advanced, unresectable gastric cancer found that adding lentinan to standard chemotherapy prolonged survival and improved quality of life, compared with chemotherapy alone.² A larger 2017 meta-analysis went further: it pooled 17 controlled trials and 1,423 patients across gastrointestinal and lung cancers. It found a higher one-year survival rate and overall response rate in the lentinan-plus-chemotherapy groups, with fewer severe side effects. But the two-year survival difference wasn't statistically significant, and the authors called for larger, longer trials.³

None of that evidence involves oral shiitake extract, and none of it comes from UK-regulated trials. It doesn't transfer to general use, either. These were cancer patients receiving lentinan as a prescription-controlled add-on, under close medical supervision, not healthy adults taking a daily capsule. No shiitake supplement sold in the UK is licensed as a medicine. Nothing in this evidence base supports using an over-the-counter product to treat, prevent, or aid recovery from cancer. If you're undergoing cancer treatment, run any supplement use past your oncology team first: there's a real risk of interaction with chemotherapy drugs.

Lentinan has also been trialled in HIV-positive patients, based on the same NK-cell and macrophage-activating rationale. A placebo-controlled phase I/II trial found it was well tolerated, but it didn't show a clear clinical benefit over placebo on the main endpoints.⁴ That's a useful data point on lentinan's mechanism and safety in humans. But it's another injectable, disease-specific trial, and it says little about what a food-grade capsule does.

The Oral Evidence: What Happens When You Actually Eat Shiitake

Away from the injectable cancer literature, there's a smaller but genuinely relevant body of research on eating shiitake as food. The most-cited example is a four-week randomised trial in healthy young adults who ate dried shiitake daily. Compared with a control period, the shiitake group showed higher circulating gamma-delta T-cells and roughly double the level of a specific NK T-cell subset. Salivary IgA rose too, and a marker of systemic inflammation fell.⁵

That trial matters because it's one of the few showing an immune effect from realistic, food-level intake rather than an injected drug dose. But it's also small and short, and it measures immune biomarkers, not clinical outcomes like infection rates or illness duration. Read alongside the cancer-trial data, the honest picture is this: lentinan clearly does something to human immune cells, whether by injection or, to a lesser extent, by mouth. What that translates to for day-to-day health outside a research setting is still thin ground.

Why Bioavailability Is the Real Bottleneck

The gap between injectable and oral lentinan comes down to absorption. Lentinan is a large molecule, and large molecules don't cross the gut wall easily. Researchers studying the mechanism found lentinan does enter intestinal cells, through a slow process called endocytosis, but only in small amounts.⁶ Oral bioavailability estimates sit in the low single digits, commonly cited around 1.5 to 3%. That's one reason the pharmaceutical form is injected rather than swallowed.

This doesn't mean oral shiitake does nothing. The dietary trial above shows a measurable immune signal from food-level intake despite that poor absorption. Gut-associated immune tissue may also respond to lentinan locally, without the compound needing to reach the bloodstream in large amounts. But it does mean a "500mg extract, 30% beta-glucans" capsule and a "5mg IV lentinan" clinical dose are not two doses of the same thing. They're two different delivery systems with very different absorption profiles. Extraction method matters here too. Hot-water extraction, the traditional method for isolating beta-glucans, tends to yield a more soluble, more active fraction than a crude powdered mushroom. Few UK labels state their extraction method clearly enough to compare.

Reading a UK Shiitake Supplement Label

Given the bioavailability picture, what should actually change your buying decision? A few label details tell you more than the headline milligram figure:

• Fruiting body vs. mycelium on grain. Fruiting body material contains meaningfully higher beta-glucan and lentinan content than mycelium grown on grain substrate, which can be diluted with starch. UK labels don't always distinguish clearly, so look for "fruiting body" stated explicitly.
• A stated beta-glucan or polysaccharide percentage. A product listing "40% polysaccharides, 30% beta-glucans" is telling you something concrete about content. A product that only says "1,000mg shiitake extract" with no percentage could be delivering a fraction of that in actual active compound.
• Extract ratio. A "10:1" or "15:1" extract means that much raw mushroom material was concentrated into each dose, which is a reasonable proxy for potency when a beta-glucan percentage isn't disclosed separately.
• Lentinan specifically vs. general polysaccharides. Very few UK consumer products isolate and standardise lentinan itself, since that's a more specialised (and expensive) extraction process closer to the pharmaceutical-grade material. Most supplements instead standardise to total beta-glucan or polysaccharide content, of which lentinan is one component among several.

None of this changes the underlying bioavailability limitation, but it does mean you're at least buying a product whose active compound content is disclosed rather than assumed.

How Lentinan Compares to Other Mushroom Beta-Glucans

Shiitake isn't the only medicinal mushroom studied for its polysaccharide content. It's worth knowing where it sits next to the others if you're building a stack. Turkey Tail contains PSK (krestin) and PSP, beta-glucan-protein complexes with their own separately studied history as a cancer-therapy add-on in Japan. That's arguably the closest parallel to lentinan's clinical story. Reishi offers a broader beta-glucan and triterpene profile, studied more for general immune support and sleep-adjacent effects than for oncology specifically. Maitake contributes its own distinct fraction, the D-fraction, again with a separate research base.

If your goal is general immune support rather than chasing one compound, a mushroom complex spreads the polysaccharide profile across several species rather than relying on shiitake alone. That may suit people who want broader coverage without leaning on one mushroom's specific evidence gaps. No published human trial compares these species head-to-head on immune outcomes, so any combination decision here is reasoned inference, not proof of a combined effect.

FAQ

What is lentinan, exactly, and how is it different from shiitake beta-glucans in general?

Lentinan is a specific, purified beta-1,3/1,6-glucan isolated from shiitake fruiting bodies, first characterised and studied for its antitumor activity from the 1970s onward. Shiitake also contains other polysaccharides and beta-glucans more broadly; lentinan is the single most-studied and most immunologically active fraction among them.¹

Does oral lentinan from a capsule work the same way as the injectable lentinan used in Japanese cancer trials?

Not directly comparably. The clinical survival and response-rate data come from intravenous or intramuscular pharmaceutical lentinan given at 2-10mg per week alongside chemotherapy under medical supervision.^{2 3} Oral supplement lentinan reaches circulation far less efficiently, so the two shouldn't be treated as equivalent doses of the same intervention.

Is there any real evidence for immune benefits from just eating shiitake or taking an oral supplement?

Yes, though it's a smaller evidence base than the cancer-trial literature. A four-week randomised trial in healthy adults found daily dried shiitake intake raised several immune cell markers and reduced a marker of inflammation, at ordinary food-level doses rather than pharmaceutical ones.⁵

Why does bioavailability matter so much for lentinan specifically?

Lentinan's very large molecular size limits how much of it crosses the gut wall intact. Mechanistic studies estimate oral bioavailability at roughly 1.5 to 3%, achieved through slow endocytic uptake by intestinal cells rather than straightforward absorption.⁶ This is the core reason pharmaceutical lentinan is injected rather than swallowed.

Was lentinan ever tested for conditions other than cancer, like HIV?

Yes. A placebo-controlled phase I/II trial tested lentinan in HIV-positive patients based on its NK-cell and macrophage-activating properties. It was well tolerated but didn't show a clear clinical benefit over placebo on the trial's primary endpoints.⁴ It's a useful safety data point rather than evidence for a specific therapeutic use.

Are shiitake and lentinan supplements safe to take daily?

Shiitake has a long history of use as a food and is generally well tolerated at typical supplement doses. A minority of people develop a temporary skin reaction called shiitake dermatitis, usually linked to eating raw or undercooked mushroom rather than properly processed supplements.⁷ As with any supplement, speak to your GP before use if you're pregnant, breastfeeding, on medication, or undergoing cancer treatment, given the potential for interaction with chemotherapy drugs specifically.

The Bottom Line on Lentinan

Lentinan is real, well-characterised, and backed by a genuinely large body of clinical research, but almost all of the strongest data describes an injectable pharmaceutical product used as adjuvant cancer therapy in Japan and China, not a capsule from a UK supplement shelf. Oral shiitake still shows a measurable immune effect in healthy adults, just at food-level intake and through a much less efficient absorption route.

That distinction should shape expectations, not rule out oral shiitake altogether. If you want a supplement with disclosed beta-glucan content, sourced from fruiting body material, our full comparison below covers the specific UK products worth considering and what separates a well-specified extract from a vague one.